by Sandrine Miller | Apr 6, 2021 | Press
Jennifer Wargo, M.D., leads research on link between microbiome and cancer treatment and recently co-authored Science review with Micronoma founders San Diego, Calif. (April 6, 2021) – San Diego, Calif. Micronoma, the first cancer detection biotech company that...
by Sandrine Miller | Feb 17, 2021 | Press
Investors more than double funding base for cancer microbiome diagnostic company to accelerate go-to-market timeline six months after seed February 17, 2021 — San Diego, Calif. Micronoma, the first cancer detection biotech company that utilizes signals from the...
by Sandrine Miller | Dec 9, 2020 | Press
International oncology, microbiome and drug discovery expertise synergize to guide unique early cancer detection startup SAN DIEGO, Dec. 9, 2020 /PRNewswire/ — Micronoma, the first cancer detection biotech company that uses signals from the tumor-related...
by Sandrine Miller | Nov 5, 2020 | Press
Innovative early cancer detection company establishes headquarters and adds three key executive positions San Diego, Calif. (November 5, 2020). Micronoma, an early-stage cancer detection biotech company seeking to develop and commercialize a minimally-invasive, unique...
by Sandrine Miller | Sep 30, 2020 | Press
Biotech maven joins early-stage cancer detection company utilizing innovative microbiome analysis SAN DIEGO, Sept. 30, 2020 /PRNewswire/ — Micronoma, an early stage cancer-detection start-up seeking to develop and commercialize a minimally-invasive, unique...
by Sandrine Miller | Aug 12, 2020 | Press
For Immediate Release Media Contact: Celia Sepulveda, Celia.Sepulveda@Micronoma.com, 858.337.1326 Micronoma Launches with $3 Million Seed Funding First early cancer-detection company to use microbial biomarkers in diagnostics San Diego, Calif....
